SCHEMBL10270565

SCHEMBL10270565

CC(C)NC(=O)[C@]1(O)CC[C@H](C(C)C)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
OPRL1 P41146 3/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
MMP2 P08253 2/20 0.32
CA9 Q16790 2/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
OPRM1 P35372 2/20 0.30
ROCK2 O75116 1/20 0.30
ROCK1 Q13464 1/20 0.30
HCRTR2 O43614 1/20 0.30
MME P08473 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ACACB O00763 1/20 0.30
LMNA P02545 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10270568 0.83 OPRL1 (0.42) OPRL1OPRM1ROCK2ROCK1
SCHEMBL15199109 0.83 ALDH1A1 (0.34) ALDH1A1OPRL1MEN1KMT2AL3MBTL1
SCHEMBL18213840 0.82 ALDH1A1 (0.40) ALDH1A1CA12CA1CA2MMP2
SCHEMBL23903956 0.80 OPRL1 (0.34) OPRL1OPRM1ROCK2ROCK1SMN1; SMN2
SCHEMBL13990339 0.80 ALDH1A1 (0.42) ALDH1A1CA12CA1CA2MMP2
SCHEMBL8070148 0.76 OPRL1 (0.31) OPRL1ROCK2ROCK1
SCHEMBL14652117 0.73 KDM5A (0.38) OPRL1L3MBTL1OPRM1ROCK2ROCK1
SCHEMBL13990338 0.71 ALDH1A1 (0.38) ALDH1A1CA12CA1CA2MMP2
SCHEMBL14041686 0.69 ALDH1A1 (0.37) ALDH1A1CA12CA1CA2MMP2
SCHEMBL25444136 0.69 KDM5A (0.36) ALDH1A1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 WO disclosed